1. Home
  2. GNTX vs PTCT Comparison

GNTX vs PTCT Comparison

Compare GNTX & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gentex Corporation

GNTX

Gentex Corporation

HOLD

Current Price

$24.08

Market Cap

5.0B

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$73.13

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNTX
PTCT
Founded
1974
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
5.7B
IPO Year
1995
2006

Fundamental Metrics

Financial Performance
Metric
GNTX
PTCT
Price
$24.08
$73.13
Analyst Decision
Hold
Buy
Analyst Count
5
17
Target Price
$26.60
$80.65
AVG Volume (30 Days)
2.5M
1.3M
Earning Date
04-24-2026
05-07-2026
Dividend Yield
2.10%
N/A
EPS Growth
N/A
264.48
EPS
1.00
0.90
Revenue
$2,534,268,965.00
$264,734,000.00
Revenue This Year
$6.89
N/A
Revenue Next Year
$4.58
$17.70
P/E Ratio
$23.54
$78.72
Revenue Growth
9.55
36.19
52 Week Low
$20.48
$43.18
52 Week High
$29.38
$90.87

Technical Indicators

Market Signals
Indicator
GNTX
PTCT
Relative Strength Index (RSI) 45.43 37.38
Support Level $22.50 $68.16
Resistance Level $24.03 $72.09
Average True Range (ATR) 0.63 3.11
MACD 0.03 -0.99
Stochastic Oscillator 60.44 39.28

Price Performance

Historical Comparison
GNTX
PTCT

About GNTX Gentex Corporation

Gentex was founded in 1974 to produce smoke-detection equipment. The company sold its first glare-control interior mirror in 1982 and its first model using electrochromic technology in 1987. Automotive revenue is about 98% of total revenue. The company is constantly developing new applications for the technology to remain on top. Sales in 2024 totaled about $2.3 billion, with 47.7 million mirrors shipped. The unit mix breaks out as 63% interior and 37% exterior, versus 31% exterior in 2019. The company is based in Zeeland, Michigan.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: